Status:

UNKNOWN

Protective Mechanical VENTilation Strategy in Patients Undergoing CARDiac Surgery

Lead Sponsor:

University Health Network, Toronto

Conditions:

Pulmonary Complications

Cardiac Surgery

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Heart surgery is a life-saving intervention for hundreds of thousands of patients each year worldwide. Advances in technology and medical expertise have improved outcomes for these patients over the y...

Detailed Description

Postoperative pulmonary complications are frequent after cardiac surgery, affecting approximately 30% of all patients. Such complications result in increased morbidity, mortality and health care utili...

Eligibility Criteria

Inclusion

  • Age \> 18 years old
  • Scheduled for elective Coronary Artery Bypass Graft, Single valve repair or replacement, or Coronary Artery Bypass Graft plus Single Valve repair or replacement, with the use of Cardiopulmonary Bypass (CPB), aortic clamp and cardioplegia, sternotomy

Exclusion

  • Pregnancy
  • Clinically significant Congenital Heart Disease
  • Surgery with planned thoracotomy approach with one lung ventilation
  • Body mass index (the weight in kilograms divided by the square of the height in meters) of 40 or higher,
  • Receipt of positive pressure mechanical ventilation (invasive and non-invasive) within the 2 weeks preceding surgery (excluding routine treatment for obstructive sleep apnea syndrome)
  • Severe chronic respiratory disease, as indicated by any of:
  • Baseline FEV1 \< 20 ml/kg predicted body weight
  • Pre-existing chronic interstitial lung disease with chronic interstitial infiltration on chest X-ray
  • Documented chronic CO2 retention (PaCO2 \> 50 mm Hg) and/or chronic hypoxaemia (PaO2\<55 mmHg on FiO2 = 0.21)
  • Chronic restrictive, obstructive, neuromuscular, chest wall or pulmonary vascular disease resulting in severe exercise restriction (e.g., unable to climb stairs or perform household duties), secondary polycythaemia, severe pulmonary hypertension (mean PAP \> 40 mmHg), or ventilator dependency
  • Requirement for urgent/emergent surgery
  • Progressive neuromuscular illness\* that will result in prolonged need for mechanical ventilation
  • Previous randomization in this trial
  • Consent refusal
  • Surgeon, anesthesiologist, intensivist refusal

Key Trial Info

Start Date :

July 7 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2022

Estimated Enrollment :

310 Patients enrolled

Trial Details

Trial ID

NCT03288558

Start Date

July 7 2017

End Date

April 1 2022

Last Update

April 30 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Toronto General Hospital, University Health Network

Toronto, Ontario, Canada, M5G 2C4

Protective Mechanical VENTilation Strategy in Patients Undergoing CARDiac Surgery | DecenTrialz